SA22
SA22
规格:
货期:
编号:TS210951
品牌:Testobio
| 产品名称： | SA22 |
|---|---|
| 商品货号： | TS210951 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with rboIL-1 beta and cross-reacts with its human analog (rHuIL-1 beta). The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Derivation： | Animals were immunized with purified rboIL-1 beta. Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against bovine recombinant interleukin 1 beta (rboIL-1 beta) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against bovine recombinant interleukin 1 beta (rboIL-1 beta) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified rboIL-1 beta. Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibody reacts with rboIL-1 beta and cross-reacts with its human analog (rHuIL-1 beta). It does not react with other related monokines tested (ie.g., human IL-6 and TNF alpha). The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Complete Growth Medium： | Dulbeccos modified Eagles medium with 4.5 g/L glucose, 1 mM non-essential amino acids, 0.1 mM hypoxanthine, 0.032 mM thymidine and BME vitamins, 70%; hybridoma cloning factor (Origen), 10%; fetal bovine serum, 20%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | F Blecha |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Reddy DN, et al. Isolation and characterization of monoclonal antibodies to recombinant bovine interleukin-1 beta. Vet. Immunol. Immunopathol. 36: 17-29, 1993. PubMed: 7680508 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
SA22
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | SA22 |
|---|---|
| 商品货号： | TS210951 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications： | The antibody reacts with rboIL-1 beta and cross-reacts with its human analog (rHuIL-1 beta). The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Derivation： | Animals were immunized with purified rboIL-1 beta. Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against bovine recombinant interleukin 1 beta (rboIL-1 beta) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against bovine recombinant interleukin 1 beta (rboIL-1 beta) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified rboIL-1 beta. Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibody reacts with rboIL-1 beta and cross-reacts with its human analog (rHuIL-1 beta). It does not react with other related monokines tested (ie.g., human IL-6 and TNF alpha). The antibodies neutralizes IL-1 activity (both macrophage derived IL-1 and recombinant IL-1 beta) in a thymocyte costimulation assay. |
| Complete Growth Medium： | Dulbeccos modified Eagles medium with 4.5 g/L glucose, 1 mM non-essential amino acids, 0.1 mM hypoxanthine, 0.032 mM thymidine and BME vitamins, 70%; hybridoma cloning factor (Origen), 10%; fetal bovine serum, 20%
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | F Blecha |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| References： | Reddy DN, et al. Isolation and characterization of monoclonal antibodies to recombinant bovine interleukin-1 beta. Vet. Immunol. Immunopathol. 36: 17-29, 1993. PubMed: 7680508 |
